MAPT and Huntington disease: Additionally, SIRT3-5 exert neuroprotective effects by restraining pathological tau aggregation in AD, repressing dopaminergic neuronal degeneration in PD, and promoting the antioxidant effect in cells expressing mHtt in HD.